FTSE 100 seen giving up some vaccine gains after dose of pragmatism
The FTSE 100 has been tipped to give up a chunk of its gains from the start of the week as the initial shot in the arm from the Pfizer coronavirus vaccine news wears off quickly.
London’s blue chip index is seen falling 88 points or 1.4% on Tuesday, according to the IG spread-betting platform, after adding 276 points or 4.7% to 6,186.3 the day before.
Wall Street had a mixed time overnight, with the Dow Jones and the S&P 500 up 2.95% and 1.2% but the Nasdaq Composite falling 1.5% as eight of the top ten tech giants saw billions knocked off their valuations.
Asian stocks are mostly higher this morning as they missed out on the vaccine bounce yesterday, with the Hang Seng and and Nikkei up slightly but the Shanghai composite in the red.
“The new record highs for the Dow, S&P500 and Russell 2000 certainly point to a much greater sense of optimism than at any other time this year, however it still doesn’t hurt to exercise a degree of caution, at a time of still highly elevated levels of uncertainty,” said market analyst David Madden at CMC.
“The results of the Pfizer study are certainly welcome news, a 90% success rate is certainly well above expectations, and as such is a very much needed beacon of light in what has been a dark year for the global economy, however one swallow does not make a summer, and there still remains a some way to go before life as we knew it a year ago, can return to any semblance of normal, in the short or medium term.
“Not only do we have the small matter of trying to navigate the current problems the virus is causing in terms of new lockdowns, the vaccine trial data still needs to be parsed, and as WHO Special Envoy David Nabarro stated yesterday, last stage assessments will still be key in determining whether the vaccine obtains final approval.”
Around the markets
Pound is up 0.1% at US$1.3178
Gold is up 1% at US$1,885.14 after falling 3.8% yesterday
Brent Crude Oil up 5.7% to US$41.96
6.45 am: Early Markets: Asia / Australia
Stocks in Asia-Pacific were mostly higher as investors reacted to positive developments overnight on the COVID-19 vaccine front.
Japan’s Nikkei 225 advanced 0.26% while South Korea’s Kospi gained 0.18%.
In China, the Shanghai composite dipped 0.62% as Hong Kong’s Hang Seng index added 0.29%.
Shares in Australia advanced, with the S&P/ASX 200 gaining 0.66%.
Proactive Australia news:
Little Green Pharma Ltd (ASX:LGP) has entered into a strategic partnership with national private health insurer Health Insurance Fund of Australia (HIF) for continued development of medicinal cannabis as a treatment for Australian patients.
Elementos Limited (ASX:ELT) (OTCMKTS:ELTLF) (FRA:9EM) has intersected visible mineralisation in four of the initial six diamond drill holes completed in 2020 exploration drilling at the flagship Oropesa Tin Project in Spain.
Macarthur Minerals Ltd (ASX:MIO) (CVE:MMS) (OTCQB:MMSDF) is set to become ‘the green iron ore company’ with its Lake Giles Iron Project in Western Australia to be at the fore of a new global iron ore future that values more sustainable steel products derived from responsible mining practices.
Alicanto Minerals Ltd (ASX:AQI) has hit chalcopyrite copper at Heden East prospect, the second regional target drilled within the Greater Falun Copper-Gold Project in Sweden and has repeated the success from the first target, Green Mile.
Blackstone Minerals Ltd (ASX:BSX) continues its aggressive exploration program testing multiple massive sulphide vein (MSV) prospects throughout the Ta Khoa nickel sulphide district in northern Vietnam.
Kin Mining NL (ASX:KIN) (FRA:8KM) has started a maiden mineral resource estimate for the Cardinia Hill deposit at the 100%-owned Cardinia Gold Project (CGP) near Leonora in Western Australia, following the receipt of further thick high-grade results from infill drilling.